Email this article The efficacy of the TRK inhibitor entrectinib in patients with extracranial NTRK fusion-positive tumors - PDF (Russian)
Copyright (c) 2023 «D. Rogachev NMRCPHOI»
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 «D. Rogachev NMRCPHOI»
This work is licensed under a Creative Commons Attribution 4.0 International License.